In this video clip from our Industry Outlook interview with him back in March 2025, Tore Bergsteiner, managing partner at MAIN5, a European consulting firm specializing in digitally enabled change for life sciences R&D organizations, discusses how AI is increasingly enhancing diagnostics and pathology by enabling early disease detection through advanced image analysis, improving treatment outcomes and patient safety. He also notes how AI helps address global shortages of pathologists by boosting diagnostic efficiency and accuracy. Both points still hold true 4 months later.
